Jounce Therapeutics, Inc. insider trading activity
Understanding Insider Activity at Jounce Therapeutics, Inc.
Welcome to our dedicated page for Jounce Therapeutics, Inc. (Nasdaq: JNCE) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Jounce Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Jounce Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for JNCE| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| JNCE | 08:37:50 PM, 04/06/2023 | MURRAY RICHARD /CA/ sold 39228 shares of Jounce Therapeutics, Inc. (JNCE) for ~$72571 | Filing |
| JNCE | 01:33:01 AM, 01/12/2023 | Trehu Elizabeth(Chief Medical Officer) sold 9285 shares of Jounce Therapeutics, Inc. (JNCE) for ~$10315 | Filing |
| JNCE | 01:32:15 AM, 01/12/2023 | MURRAY RICHARD /CA/(CEO and President) sold 45070 shares of Jounce Therapeutics, Inc. (JNCE) for ~$50074 | Filing |
| JNCE | 01:30:22 AM, 01/12/2023 | Drapkin Kimberlee C(CFO and Treasurer) sold 14096 shares of Jounce Therapeutics, Inc. (JNCE) for ~$15660 | Filing |
| JNCE | 01:29:28 AM, 01/12/2023 | Cole Hugh M(Chief Operating Officer) sold 16634 shares of Jounce Therapeutics, Inc. (JNCE) for ~$18480 | Filing |